The adverse event profile of pregabalin across different disorders: a meta-analysis
- 21 January 2012
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 68 (6), 903-912
- https://doi.org/10.1007/s00228-012-1213-x
Abstract
In a recent meta-analysis of 38 double-blind randomized controlled trials (RCTs) comparing pregabalin (PGB) to placebo, we found 20 adverse events (AEs) to be significantly associated with PGB treatment. In the present study, we evaluated whether the incidence of these 20 AEs differs across distinct disorders in which PGB was investigated.Keywords
This publication has 45 references indexed in Scilit:
- The adverse event profile of pregabalin: A systematic review and meta‐analysis of randomized controlled trialsEpilepsia, 2011
- Epilepsy, cognition, and behavior: The clinical pictureEpilepsia, 2011
- Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trialBMC Neurology, 2008
- New Insights into the Placebo and Nocebo ResponsesNeuron, 2008
- Efficacy and Safety of Pregabalin in the Treatment of Generalized Anxiety DisorderThe Journal of Clinical Psychiatry, 2006
- Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13‐week, randomized trialCurrent Medical Research and Opinion, 2005
- Pregabalin Add‐on Treatment in Patients with Partial Seizures: A Novel Evaluation of Flexible‐dose and Fixed‐dose Treatment in a Double‐blind, Placebo‐controlled StudyEpilepsia, 2005
- Pregabalin Add‐on Treatment: A Randomized, Double‐blind, Placebo‐controlled, Dose–Response Study in Adults with Partial SeizuresEpilepsia, 2003
- Measuring inconsistency in meta-analysesBMJ, 2003
- Correlation Between Daily Fluctuations of Carbamazepine Serum Levels and Intermittent Side EffectsEpilepsia, 1980